ArticleNanomedicine : nanotechnology, biology, and medicine2022

Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response.

Qiong Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.